Article Figures & Data
Tables
Drug Available doses Frequency and route Dose approved for weight management Exenatide 5 μg, 10 μg Twice daily subcutaneously Not approved Liraglutide 0.6 mg, 1.2 mg, 1.8 mg Once daily subcutaneously 0.6 mg once daily for 1 week, increase by 0.6 mg daily at weekly intervals to a target dose of 3 mg once daily Exenatide extended-release 2 mg Once weekly subcutaneously Not approved Dulaglutide 0.75 mg, 1.5 mg, 3 mg, 4.5 mg Once weekly subcutaneously Not approved Semaglutide 0.25 mg, 0.5 mg, 1 mg, 2 mg Once weekly Titrate every 4 weeks:
0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg once weeklySemaglutide, oral 3 mg, 7 mg, 14 mg Once daily by mouth Not approved Liraglutide-insulin degludec 0.36 mg-10 U
0.5 mg-16 UOnce daily subcutaneously Not approved Lixisenatide-insulin glargine 5 μg-15 U
10 μg-30 UOnce daily subcutaneously Not approved Tirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg Once weekly subcutaneously Not approved